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Original Research

Gene Expression in Meniscal Tears at the
Time of Arthroscopic Partial Meniscectomy
Predicts the Progression of Osteoarthritis
Within 6 Years of Surgery
Joseph D. Lamplot,* MD, Muhammad Farooq Rai,†‡ PhD, William P. Tompkins,† BS,
Michael V. Friedman,§ MD, Eric J. Schmidt,|| PhD, Linda J. Sandell,†‡ PhD,
and Robert H. Brophy,†{ MD
Investigation performed at Washington University School of Medicine, St Louis, Missouri, USA
Background: While knees with meniscal tears are associated with a heightened risk of developing osteoarthritis (OA), it is difficult
to predict which patients are at the greatest risk for OA. Gene signatures in menisci that are resected during arthroscopic partial
meniscectomy (APM) may provide insight into the risk of OA progression.
Hypothesis: Meniscal gene signatures at the time of APM will predict radiographic OA progression.
Study Design: Case series; Level of evidence, 4.
Methods: Meniscal fragments were collected from 38 patients without OA during clinically indicated APM of the medial meniscus.
The expression of 28 candidate genes with known roles in cartilage homeostasis, OA, extracellular matrix degradation, and obesity
was assessed by quantitative real-time polymerase chain reaction. Weightbearing radiographs obtained before surgery and at final
follow-up were graded by a musculoskeletal radiologist using the Kellgren-Lawrence classification of OA. The association of
meniscal gene expression at baseline with the progression of radiographic OA was determined.
Results: Gene expression and baseline and follow-up radiographic data were available from 31 patients (81.6%) at a mean follow-up
of 6.2 ± 1.3 years. Patients without OA progression had significantly higher expression of 7 genes: MMP9 (5.1-fold; P ¼ .002), IL8
(2.9-fold; P ¼ .016), CCL3 (3.7-fold; P ¼ .032), CCL3L1 (4.5-fold; P ¼ .008), CXCL6 (6.2-fold; P ¼ .010), LEP (5.2-fold; P ¼ .004),
and RETN (46-fold; P ¼ .008).
Conclusion: Gene expression in the meniscus at the time of APM may be associated with the risk for progression of OA after
surgery. Elevated expression of the aforementioned genes may reflect a chondroprotective response. Stratifying the risk for
OA progression after APM could facilitate targeted interventions to delay or prevent the development of OA. Further studies
in a larger cohort with an extended follow-up, and inclusion of additional genes, are warranted to better characterize this
association.
Keywords: meniscectomy; meniscal tear; osteoarthritis; gene expression

Osteoarthritis (OA) is the most common degenerative joint
disorder, resulting in disability and financial burden in the
United States and around the world.40 One reason for its
high prevalence may be a lack of information regarding the
early molecular events that initiate the disease process.
Currently, knee OA is diagnosed in its late stages by radiographs reflecting significant articular cartilage loss, at
which time little can be done to delay, halt, or reverse its
progression. Oftentimes, total knee arthroplasty (TKA) is
the only effective treatment. Interventions at earlier stages

may be able to delay or even prevent OA progression such
that joint replacement could be delayed or avoided. Meniscal degeneration is highly prevalent in patients with
OA.14,37 However, it is not currently possible to predict
which patients with meniscal tears are at the highest risk
for developing OA that may require joint replacement, nor
is it possible to predict the timeline for OA progression in
these patients. While meniscal tears are known to lead to
OA in 30% to 75% of patients,8,19,21,25 few studies have
explored how the biology of the injured meniscus relates
to OA pathogenesis,2,3,30,31,35,37 making it difficult to stratify the risk of progression.
Arthroscopic partial meniscectomy (APM) is an effective
treatment for symptomatic meniscal tears, but it does not
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slow OA progression.6,8,10,19,21 After surgery, patients often
recover within several months. Other than some physical
therapy, patients often receive little or no additional interventions unless the knee continues to be symptomatic or
develops new symptoms. However, many of these patients
still develop OA, as the meniscal injury itself may initiate a
cascade of changes within the knee or reflects pre-existing
changes in the joint that lead to OA. 2,8,19,21,37 Injured
meniscal tissue that is debrided at the time of surgery is
generally disposed of, but it is possible that this readily
available tissue contains information that may provide
insight into each individual patient’s risk of OA progression. Developing more sensitive and specific means to
determine a patient’s risk for OA progression could facilitate targeted interventions to slow or stop the progression of OA. This could shift the paradigm of treatment
for knee OA after a meniscal injury from end-stage reactive treatment with injections and TKA to earlier proactive efforts to slow or stop the disease process using
known and yet-to-be discovered interventions.
Previous studies have suggested that OA development is
associated with gene expression levels of cytokines, chemokines, matrix metalloproteinases, aggrecanases, and other
inflammation-related genes within the meniscus of noninjured knees,26,41 at the time of APM in the setting of meniscal injuries,2,3,27,28,30,31 and at the time of TKA in knees
with end-stage OA.35,37 However, no study has investigated the association of gene expression in the injured
medial meniscus at the time of APM with the progression
of OA. The objective of this study was to investigate the
radiographic outcomes of a cohort of patients who previously underwent arthroscopic partial medial meniscectomy
and their association with gene expression data available
from meniscal samples collected at the time of surgery.2,3
The study hypothesis was that differential expression of
OA-related genes will be associated with the progression
of knee OA in patients with medial meniscal injuries treated with APM.

METHODS
The study site’s institutional review board approved this
protocol. Meniscal fragments were collected at the time of
clinically indicated APM for isolated medial meniscal tears
from 38 consenting patients meeting inclusion criteria, and
{
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gene expression was characterized by quantitative real-time
polymerase chain reaction as previously described.2,3,30
Custom-designed primers2,3,30 were obtained from Invitrogen for a panel of 28 candidate genes based on their known
role in cartilage homeostasis, OA, and extracellular matrix
degradation2,30 as well as selected markers for obesity28,29
including adiponectin (ADIPOQ), apelin (APLN), leptin
(LEP),11 and resistin (RETN).24 Briefly, we evaluated the
expression of proinflammatory cytokines IL-1a, IL-1b, IL-6,
and TNFa2 as well as chemokines IL-8, CCL3, CCL3L1,
CXCL1, CXCL6, and CCL20. The expression of matrixdegrading enzymes ADAMTS4, ADAMTS5, MMP-1, MMP3, MMP-9, and MMP-13 was assessed. Matrix molecules
BMP-2, COL1A1, COL2A1, and ACAN as well as transcription factors NFkB2, NFkBIA, and IkBA were also evaluated.
All patients underwent a single series of knee radiographs
(standing anteroposterior, Rosenberg, lateral, and Merchant
views) at the time of the initial preoperative clinic visit and
at final follow-up. Baseline age, sex, and body mass index
(BMI) were collected and recorded. A single academic
musculoskeletal radiologist who was blinded to gene expression data (M.V.F.) graded the preoperative and final
follow-up radiographs according to the Kellgren-Lawrence
classification of OA.7,17 The modified Kellgren-Lawrence
classification allows for patients to be dichotomized as having “incident OA,” defined as joint space narrowing and an
osteophyte, with at least 1 of these being new or “no incident
OA.”7 Radiographic progression was quantified as an
increase by at least 1 Kellgren-Lawrence grade within a
compartment. Patients with rapid progression were those
who had incident OA as defined above.7,17
We compared patients without OA progression in any
compartment of the knee to those with progression in any
compartment of the knee, patients without any progression
in the medial compartment to those with progression in the
medial compartment, and patients without rapid progression in the medial compartment to those with rapid
progression in the medial compartment. Finally, we compared the entire cohort between those with no progression
in the knee, those with progression but not in the medial
compartment, those with some progression but not rapid
progression in the medial compartment, and those with
rapid progression in the medial compartment. No patients
had rapid progression in the lateral and/or patellofemoral
compartments without also having rapid progression in the
medial compartment.
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TABLE 1
Characteristics of Study Patientsa
Sex, n (%)
Male
Female
Age, y
BMI, kg/m2
Follow-up time, y
Radiographic OA progression, n (%)
None
Progression in any compartment
Progression in medial compartment
Rapid progression in medial compartment

17 (54.8)
14 (45.2)
48.5 ± 9.2
28.1 ± 5.1
6.2 ± 1.3
4 (12.9)
27 (87.1)
21 (67.7)
17 (54.8)

a
Data are presented as mean ± SD unless otherwise stated.
BMI, body mass index; OA, osteoarthritis.

Statistical Analysis
Based on previous studies reporting that approximately 36%
of patients are expected to demonstrate radiographic progression of OA at 5 years after APM,22,33 an a priori power
calculation with an effect size of 0.5, alpha of .05, and power
of 0.8 was performed and demonstrated a required minimum
sample size of 26 patients. Quantitative real-time polymerase
chain reaction data were analyzed using the 2–DDCT method.36
For each gene in the analysis, normalized fold changes
(2–(target gene CT – housekeeping gene CT)) in patients showing no
radiographic progression of OA were averaged and treated as controls. The normalized fold changes of patients
with progression of OA were averaged and compared
with controls using a t test, setting the level of significance to .05. Fold change was calculated by dividing the
OA average by the control average. When patients with
OA were separated into groups by severity, analysis
of variance, followed by a Tukey post hoc pairwise comparison, was performed. Analyses were performed in
SPSS (Version 25; IBM).

RESULTS
Follow-up radiographs were obtained on 31 of the initial 38
patients (81.6%) at a mean follow-up of 6.2 ± 1.3 years
(Table 1). At the time of APM, the cohort had a mean age
of 48.5 ± 9.2 years and a mean BMI of 28.1 ± 5.1 kg/m2, with
45.2% being female.
Patients with a progression of radiographic OA had
significantly lower expression of 7 genes (Figure 1). Specifically, there was a 5.1-fold decrease in MMP9 (P ¼ .002),
2.9-fold decrease in IL8 (P ¼ .016), 3.7-fold decrease in
CCL3 (P ¼ .032), 4.5-fold decrease in CCL3L1 (P ¼ .008),
6.2-fold decrease in CXCL6 (P ¼ .010), 5.2-fold decrease in
LEP (P ¼ .004), and 46-fold decrease in RETN (P ¼ .008).
None of the other candidate genes tested reached formal
significance (Table 2).
When segregating patients based on the severity of OA
progression, there was significantly increased expression of
3 genes among patients without any radiographic OA progression (Figure 2). Specifically, there was increased

3

expression of MMP9 among patients without progression
compared to those with progression in the lateral and/or
patellofemoral compartments (7.2-fold; P ¼ .038) and compared to those with rapid progression in the medial compartment (5.0-fold; P ¼ .023). There was increased
expression of CXCL6 (9.5-fold; P ¼ .042) and LEP
(4.3-fold; P ¼ .047) among those without any radiographic
OA progression compared to those with rapid progression
in the medial compartment.
Post hoc analysis was performed to assess the effect of
patient age and BMI as well as tear pattern. Adjusting
for patient age and BMI did not change the results.
In patients without any radiographic OA progression, a
tear characterized as “degenerative” was found in 75% of
patients and “traumatic” in 25% of patients. Analysis of
patients with a progression of radiographic OA demonstrated “degenerative” tears in 83% and “traumatic” tears
in 17%.

DISCUSSION
The association of gene expression in the injured meniscus
at the time of APM with progression of radiographic OA
within 6 years of surgery is a novel finding with potentially
important implications for predicting and preventing the
development of OA after this common injury. Previous
studies have investigated gene expression of the meniscus
one snapshot at a time (ie, at the time of TKA or
APM)2,3,27,28,30,31,34,35,37 but not how it may be associated
with the progression of radiographic OA. This study provides the first evidence that gene expression signatures at
the time of partial meniscectomy can predict the progression of OA at medium-term follow-up. Patients without any
radiographic OA progression had increased expression of
several OA- and obesity-related genes in the meniscus at
the time of APM. As these genes have been implicated in
the pathogenesis of OA or obesity,2,3,12,13,16,26,41,42 the reason for their elevated expression in the meniscus of nonprogressors at the time of surgery is not immediately clear.
One possible explanation is that the expression of these
genes represents a repair response in the metabolic activity
of the meniscus after an injury, which may be chondroprotective, as these patients had no radiographic OA at baseline or final follow-up.
Much of the available research on the pathogenesis of OA
has focused on biological activity within articular cartilage.39 However, recent studies have investigated how differing biological activities within the meniscus and
articular cartilage relate to OA. Brophy et al5 recently
reported clustering of meniscal transcripts among patients
undergoing APM without OA compared to those with endstage OA undergoing TKA. Patients with non-OA menisci
exhibited a “repair” phenotype compared with a more
inflammatory phenotype in the menisci of patients undergoing TKA.5 In a similar study, the authors characterized
the gene expression profile of articular cartilage in patients
with meniscal tears undergoing APM and in patients with
end-stage OA undergoing TKA.32 The authors reported distinct sets of OA transcripts between these 2 groups of
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Figure 1. Gene transcripts differentially expressed between patients who showed radiographic osteoarthritis (OA) progression at
follow-up (“Some”) and those who did not (“No”).
TABLE 2
Normalized Expression of All Candidate Genes Testeda
Gene Symbol
IL1A
IL1B
IL6
TNFA
ADAMTS4
ADAMTS5
BMP2
MMP1
MMP3
MMP9
MMP13
IL8
CCL3
CCL3L1
CXCL1
CXCL3
CXCL6
CXCL20
COL1A1
COL2A1
ACAN
NFKB1A
NFKB2
IKBA
ADIPOQ
APLN
LEP
RETN

Gene Name

No OA Progression

Interleukin 1 alpha
Interleukin 1 beta
Interleukin 6
Tumor necrosis factor alpha
A disintegrin and metalloproteinase with thrombospondin motif 4
A disintegrin and metalloproteinase with thrombospondin motif 5
Bone morphogenetic protein 2
Matrix metalloproteinase 1
Matrix metalloproteinase 3
Matrix metalloproteinase 9
Matrix metalloproteinase 13
Interleukin 8
Chemokine ligand 3
Chemokine ligand 3-like 1
Chemokine (C-X-C motif) ligand 1
Chemokine (C-X-C motif) ligand 3
Chemokine (C-X-C motif) ligand 6
Chemokine (C-X-C motif) ligand 20
Collagen type I alpha 1
Collagen type II alpha 1
Aggrecan
Nuclear factor kappa B1 alpha
Nuclear factor kappa B2
Inhibitory subunit of nuclear factor kappa B alpha
Adiponectin
Apelin
Leptin
Resistin

0.021 ± 0.007
0.015 ± 0.004
0.022 ± 0.006
0.004 ± 0.001
0.011 ± 0.002
0.009 ± 0.001
0.008 ± 0.002
0.012 ± 0.001
0.018 ± 0.004
0.011 ± 0.002
0.011 ± 0.002
0.020 ± 0.002
0.018 ± 0.004
0.010 ± 0.002
0.007 ± 0.001
0.003 ± 0.001
0.021 ± 0.006
0.004 ± 0.001
0.032 ± 0.060
0.020 ± 0.004
0.021 ± 0.006
0.007 ± 0.001
0.006 ± 0.001
0.023 ± 0.006
0.007 ± 0.002
0.025 ± 0.008
0.004 ± 0.001
0.061 ± 0.022

OA Progression
0.011
0.025
0.021
0.002
0.013
0.008
0.005
0.009
0.017
0.002
0.010
0.007
0.005
0.002
0.003
0.004
0.003
0.005
0.402
0.068
0.085
0.014
0.006
0.011
0.003
0.034
0.001
0.001

± 0.007
± 0.019
± 0.016
± 0.001
± 0.008
± 0.002
± 0.003
± 0.003
± 0.005
± 0.001
± 0.003
± 0.002
± 0.002
± 0.001
± 0.001
± 0.001
± 0.001
± 0.003
± 0.140
± 0.038
± 0.033
± 0.003
± 0.002
± 0.003
± 0.002
± 0.015
± 0.000
± 0.000

Data are presented as mean ± SEM. P values in bold represent statistically significant differences, OA, osteoarthritis.

a

P Value
.606
.866
.984
.306
.933
.861
.678
.770
.947
.002
.969
.016
.032
.008
.150
.806
.010
.852
.356
.656
.490
.391
.967
.267
.473
.842
.004
.008
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Figure 2. Gene transcripts differentially expressed across patients with different categories of radiographic osteoarthritis (OA)
progression (Kellgren-Lawrence grades: I [minimal], II [mild], III [moderate], IV [severe]) at follow-up based on knee compartment
and rate of progression. Label a indicates a significant difference between 2 groups (P < .05). Similarly, label b indicates a
significant difference between 2 groups (P < .05).

patients, with APM cartilage exhibiting molecular signatures reflective of OA but in an earlier stage.31,32 Interestingly, when looking at specific transcripts that were
overexpressed among patients undergoing APM in these
studies, there were no common transcripts overexpressed
in both meniscal and articular cartilage tissue. Similarly,
there were very few transcripts overexpressed in both
menisci and cartilage in patients undergoing TKA. These
findings suggest that the gene expression profiles within
the meniscus and articular cartilage differ, particularly in
the setting of a meniscal injury.
It has been estimated that 30% to 75% of patients develop
subsequent knee OA within 10 to 20 years of APM.8,19,21
While it has been suggested that degenerative tears may be
associated with radiographic OA after meniscectomy,9 few
studies have investigated the biological differences
between traumatic and degenerative tears. Brophy et al4
recently analyzed gene expression within the menisci of
patients with degenerative and traumatic tears, demonstrating that gene expression varied by tear pattern.
Patients with traumatic tears had increased expression of
certain chemokines (IL8 and CXCL6) and matrix metalloproteinases (MMP1 and MMP3). In the present study, we
demonstrated that nonprogressors had significantly
increased expression of the chemokines IL8 and CXCL6,
among other genes, compared with progressors. In the present study, we initially chose not to consider tear type
(degenerative vs traumatic), as it is often difficult to ascertain, particularly in a middle-aged patient cohort, whether
the cause was truly degenerative, traumatic, a combination
of both, or something else. After our data analysis revealed
common genes overexpressed in nonprogressors and in
patients with traumatic tears, as described in a previous
study,4 we performed a post hoc analysis comparing tear
type (degenerative vs traumatic) between nonprogressors
and progressors. This analysis demonstrated no difference
in tear type among nonprogressors and progressors. While
further analysis was not performed, it is unlikely that tear
type alone is responsible for the gene expression profile as it
relates to the progression of OA after APM.

Several previous studies have investigated gene expression of the meniscus in noninjured knees,26,38,41 at the time
of surgery in the setting of a meniscal injury,2,3,27,28,30,31
and at the time of TKA in knees with end-stage OA.35,37
Using gene expression analysis of meniscal tissue obtained
from the same cohort of patients undergoing APM as in the
present study, Brophy et al2 demonstrated significant
differences in meniscal gene expression based on age, sex,
and injury pattern, which may be clinically relevant.
Elevated expression of OA-related genes was seen in association with age and injury pattern. Among other genes, the
expression of MMP9 was significantly higher in patients
younger than 40 years, and the expression of CCL3 and
CCL3L1 was significantly higher in patients with combined
meniscal and anterior cruciate ligament tears compared
with a meniscal tear alone.2 Younger patients and patients
with a combined injury mechanism may be more likely to
mount a more robust biological response to an injury compared with older patients and compared to those with an
isolated meniscal injury, respectively. In the present study,
we demonstrated overexpression of some of these same
genes (CCL3, CCL3L1, MMP9) among nonprogressors.
While further research is necessary, it is possible that elevated expression of these and other genes within the meniscus may indicate a more robust biological response after a
meniscal injury that may be chondroprotective. Even
though several of these genes have been implicated in the
pathogenesis of OA,2,30 these nonprogressors had no radiographic OA at the time of surgery or at final follow-up. The
role of these genes specifically within the injured meniscus
remains to be defined and deserves further study.
There are several limitations to the current study. First,
as discussed earlier, we only investigated the meniscal
expression of OA- and obesity-related genes, which were
selected based on their known role in cartilage homeostasis,
OA, extracellular matrix degradation, and obesity.2,3,30 We
did not investigate non-OA genes, or genes that may protect
from OA, such as IL4 and IL10,15 IGF1,20 and IL1RA,23
among others. As mentioned earlier, we did not consider
tear type (degenerative vs traumatic), as it is often difficult
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to ascertain, particularly in a middle-aged patient cohort,
whether the cause was truly degenerative, traumatic, a
combination of both, or something else. Post hoc analysis
of the data set suggests that this would likely not have
affected the results of the study. We did not characterize
the configuration and location of the tear within the medial
meniscus for each patient and understand that this is a
limitation of the study. However, all patients did undergo
isolated partial medial meniscectomy. As this was a relatively small cohort of patients, it would have been impossible to adequately control for tear configuration, tear
location, and amount of meniscal resection.
The meniscus was selected for this study in part because
its tissue is typically disposed of at the time of partial
meniscectomy, minimizing the potential impact on the
patient compared with performing a biopsy of articular cartilage, for example. Furthermore, OA is a disease of the
entire knee joint, involving not only articular cartilage but
also the menisci and synovium.18 As such, we feel that it
was reasonable to explore the association of meniscal gene
expression and the development of OA. Future prospective
studies could investigate gene expression of menisci and
other tissue such as articular cartilage, synovial fluid, and
the synovium collected from the same patients. The study
results may not be generalizable, as it was performed at a
single academic center in a cohort that may be slightly
heavier and older than the average population undergoing
APM, although the did not change when adjusted for age
and BMI. It is not possible to discern whether these genes
were altered at the time of injury or before injury, although
that distinction is less important from a clinical perspective, as patients typically present to the clinic after a meniscal tear occurs, and this information has the greatest
potential utility in patients undergoing APM.
The study only looked at patients undergoing medial
APM, and the results may not be the same for the lateral
compartment. In addition, these results are for an intermediate follow-up at a mean 6.2 years after surgery, and they
may differ at longer follow-up. At the time of initial enrollment, patients consented to allow us to contact them for
follow-up studies in the future, but because we did not initially intend to collect medium-term clinical and radiographic follow-up data, we cannot consider this a
prospective study. The small number of nonprogressors is
a limitation of the study, which is subject to type II (beta)
errors. Finally, we were only able to determine an association of gene expression with OA progression, not causation.
By demonstrating an association of gene expression with
OA, we are not suggesting that differential gene expression
is solely responsible for OA progression. We recognize the
biomechanical consequences of meniscectomy and their
contribution to subsequent OA.1

CONCLUSION
Increased expression of certain genes in the meniscus at
the time of APM may be associated with a lower likelihood
of OA progression at intermediate follow-up after surgery.
Future investigations should look at a larger panel of target
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genes, including those with known protective roles against
OA progression. Additionally, larger and longer longitudinal investigations are needed with respect to how gene
expression in the meniscus is associated with the risk for
the initiation and progression of knee OA. Ultimately, this
line of investigation could facilitate a more precise determination of the risk for OA progression among patients with
meniscal injuries and may be able to identify possible
approaches, including targets for novel pharmacotherapies,
to delay or prevent OA.
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